REFRACTORY BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM
Clinical trials for REFRACTORY BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM trials appear
Sign up with your email to follow new studies for REFRACTORY BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug Q702 aims to boost immune system against blood cancers
Disease control Recruiting nowThis early-stage trial tests a new drug called Q702 in people with certain blood cancers or related diseases that have not responded to other treatments. The drug works by helping the immune system attack cancer cells and supporting normal blood cell production. The study will ch…
Matched conditions: REFRACTORY BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 17, 2026 01:59 UTC
-
Engineered immune cells take aim at returning leukemia
Disease control Recruiting nowThis early-stage study tests a new treatment for children and adults with acute leukemia that has come back or not responded after a donor stem cell transplant. The treatment uses the patient's own immune cells (T cells) that are modified in a lab to recognize and attack a protei…
Matched conditions: REFRACTORY BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM
Phase: PHASE1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:40 UTC